Qizhu Yuling prescription in the prevention of postoperative metastasis and recurrence of esophagus cancer: study protocol for a randomized, double-blind, placebo-controlled, multicenter clinical trial
Authors
Jie Li (ORCID: https://orcid.org/0000-0003-0121-1291)
Qianhui Sun (ORCID: https://orcid.org/0000-0001-7685-5994)
Capital Health Research and Development of Special Fund
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Qizhu Yuling prescription in the prevention of postoperative metastasis and recurrence of esophagus cancer: study protocol for a randomized, double-blind, placebo-controlled, multicenter clinical trial
Jie Li, Qianhui Sun, Guanghui Zhu, Ying Zhang et al.
Journal
Frontiers in Oncology
Topics
Esophageal Cancer Research and Treatment
article
Qizhu Yuling prescription in the prevention of postoperative metastasis and recurrence of esophagus cancer: study protocol for a randomized, double-blind, placebo-controlled, multicenter clinical trial
Jie Li, Qianhui Sun, Guanghui Zhu, Ying Zhang, Ziyu Kuang, Kexin Liu, Zilin Wang, Bowen Xu, Miao Kong, Xinmiao Wang
article en
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in OncologyVol. 15
Institutions
Zhejiang Chinese Medical University (CN), Beijing University of Chinese Medicine (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Hunan Cancer Hospital (CN), Guang’anmen Hospital (CN)
Funders
Capital Health Research and Development of Special Fund